CinCor Pharma
United StatesWho owns CinCor Pharma?
CinCor Pharma is an American Biotech company, now owned by AstraZeneca, which acquired it in 2023 from Sofinnova Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
Sofinnova Partners sold CinCor Pharma to AstraZeneca in 2023 after 4 years.
General Atlantic sold CinCor Pharma to AstraZeneca.
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
Switzerland
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns CinCor Pharma?
CinCor Pharma is now owned by AstraZeneca, which acquired it in 2023 from Sofinnova Partners.
When did AstraZeneca acquire CinCor Pharma?
AstraZeneca acquired CinCor Pharma in 2023, buying from Sofinnova Partners.
Who did CinCor Pharma sell to?
Sofinnova Partners sold CinCor Pharma to AstraZeneca in 2023 (Trade Sale). General Atlantic sold CinCor Pharma to AstraZeneca (Trade Sale).
Who has owned CinCor Pharma over time?
CinCor Pharma has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital IX · 2019–2023 · sold to AstraZeneca · (Trade Sale); General Atlantic · via General Atlantic Growth Equity Fund · since 2019 · sold to AstraZeneca · (Trade Sale).